On 2025-05-07, Design Therapeutics, Inc. (DSGN) announced earnings per share of $-0.31 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.28.
The next expected annoucement date for quarterly earnings is 2025-08-04, with an average estimated earnings per share of $-0.32 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-07 | 2025-03-31 | $-0.28 | $-0.31 |
| 2025-03-10 | 2024-12-31 | $-0.28 | $-0.24 |
| 2024-11-07 | 2024-09-30 | $-0.26 | $-0.23 |
| 2024-08-05 | 2024-06-30 | $-0.25 | $-0.21 |
| 2024-05-08 | 2024-03-31 | $-0.28 | $-0.20 |
| 2024-03-19 | 2023-12-31 | $-0.32 | $-0.21 |
| 2023-11-13 | 2023-09-30 | $-0.42 | $-0.28 |
| 2023-08-14 | 2023-06-30 | $-0.41 | $-0.36 |
| 2023-05-09 | 2023-03-31 | $-0.37 | $-0.35 |
| 2023-03-14 | 2022-12-31 | $-0.34 | $-0.31 |
| 2022-11-03 | 2022-09-30 | $-0.28 | $-0.32 |
| 2022-08-08 | 2022-06-30 | $-0.25 | $-0.27 |
| 2022-05-09 | 2022-03-31 | $-0.22 | $-0.24 |
| 2022-03-10 | 2021-12-31 | $-0.22 | $-0.20 |
| 2021-11-09 | 2021-09-30 | $-0.14 | $-0.21 |
| 2021-08-09 | 2021-06-30 | $-0.18 | $-0.14 |
| 2021-05-10 | 2021-03-31 | $-0.06 | $-0.31 |